Responsive lawyers in demand at AstraZeneca

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Responsive lawyers in demand at AstraZeneca

Managing IP Correspondent
February 01 2006
sivborg-feb06-puff.jpg

If you are a big pharmaceutical company, spending millions of dollars to manage your intellectual property every year, you will want to find the best lawyers to advise you on prosecution and litigation matters. But as Susanne Sivborg, vice-president of global intellectual property at AstraZeneca, tells Stéphanie Bodoni, the most experienced lawyers are no good if they do not respond to her company's needs

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

FeaturesUnited StatesNorth AmericaJurisdictions
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Patents
Invest.jpg
Exclusive: Dutch IP firm VO to be acquired by private equity funder
VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
Sukanya Sarkar, June 19 2026
Managing IP Awards
Bardehle article image.jpg
Managing IP Awards interview: Prof Dr Tilman Müller-Stoy and Dr Tilman Müller
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
June 19 2026
Patents
Nokia new.jpg
This week on MIP: Nokia and Lenovo ink deal | SCOTUS turns down Judge Newman
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
Sukanya Sarkar, June 19 2026
Patents
PharmaDelawareCOVER.jpg
Weekly take: Why Hikma decision shows external factors could have increased influence
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Sanjana Mishra, June 19 2026
Trademarks
Artboard 1 copy 6@4x.png
The IP Lounge: Adding a queer lens to IP law
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Sanjana Mishra, June 18 2026
Patents
Henson_MIke_500x500 (1).jpg
Adams & Reese IP team doubles in size with blockchain practice launch
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
Sanjana Mishra, June 18 2026
Patents
Interdigital.jpg
UPC update: InterDigital nets Disney win | Kather Augenstein partner branches out
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
June 18 2026
Rankings Analysis
2026 Western Europe pic.png
UPC expansion: what’s to come in latest IP STARS rankings
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Max Walters, June 17 2026
Patents
Naomi Pearce and Peter O'Sullivan Announcement 2.png
‘Feels like coming home’: Pearce IP’s deputy-CEO on return to legal services
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Sukanya Sarkar, June 16 2026
Trademarks
CJEU
Injunctive relief without proceedings on the merits: the incompatibility of Italy’s IP Code with EU law
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Matteo Di Lernia, June 16 2026
Gift this article